Sample composition of the training and test sets
| Studied impact . | Performed comparison . | Training set (n) . | Test set (n) . | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HD . | OC . | Other cancers . | HD . | OC . | |||||||
| M . | F . | M . | F . | M . | F . | M . | F . | M . | F . | ||
| Impact of age | Samples without age as a separate feature | 158 | 110 | – | 33 | 686 | 575 | – | 71 | -– | 102 |
| Samples with age incorporated as a separate feature | 157 | 110 | – | 33 | 682 | 573 | |||||
| Impact of sex | Samples from all cases | 158 | 110 | – | 33 | 686 | 575 | -– | 71 | -– | 102 |
| Samples collected from females only | -– | 110 | -– | 33 | -– | 575 | |||||
| Impact of inclusion of other cancer types | All types of cancer | 158 | 110 | -– | 33 | 686 | 575 | -– | 71 | -– | 102 |
| Only OC cases | 158 | 110 | -– | 33 | -– | – | |||||
| Impact of combination of sex and cancer type | All samples | 158 | 110 | -– | 33 | 686 | 575 | -– | 71 | -– | 102 |
| Only OC and women raining | -– | 110 | -– | 33 | -– | -– | |||||
| Studied impact . | Performed comparison . | Training set (n) . | Test set (n) . | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HD . | OC . | Other cancers . | HD . | OC . | |||||||
| M . | F . | M . | F . | M . | F . | M . | F . | M . | F . | ||
| Impact of age | Samples without age as a separate feature | 158 | 110 | – | 33 | 686 | 575 | – | 71 | -– | 102 |
| Samples with age incorporated as a separate feature | 157 | 110 | – | 33 | 682 | 573 | |||||
| Impact of sex | Samples from all cases | 158 | 110 | – | 33 | 686 | 575 | -– | 71 | -– | 102 |
| Samples collected from females only | -– | 110 | -– | 33 | -– | 575 | |||||
| Impact of inclusion of other cancer types | All types of cancer | 158 | 110 | -– | 33 | 686 | 575 | -– | 71 | -– | 102 |
| Only OC cases | 158 | 110 | -– | 33 | -– | – | |||||
| Impact of combination of sex and cancer type | All samples | 158 | 110 | -– | 33 | 686 | 575 | -– | 71 | -– | 102 |
| Only OC and women raining | -– | 110 | -– | 33 | -– | -– | |||||
F, female; HD, healthy donors; M, male.